Table 1 Clinical characteristics of 448 participants stratified by drinking frequency

From: Frequency of alcohol drinking modifies the association between salt intake and albuminuria: a 1-year observational study

Clinical characteristics

Drinking frequency at baseline visit

P

Rare

Occasional

Daily

Number

91

235

122

 

Baseline characteristics

Age (year)*

44 (38, 51)

43 (39, 49)

50 (41, 54)

<0.001

Male (n [%])

57 (62.6)

166 (70.6)

92 (75.4)

0.129

 Smoking status (n [%])*

  Nonsmoker

81 (89.0)

183 (77.9)

68 (55.7)

<0.001

  Past smoker

7 (7.7)

33 (14.0)

38 (31.1)

  Current smoker

3 (3.3)

19 (8.1)

16 (13.1)

Current treatment for

  Dyslipidemia (n [%])

2 (2.2)

6 (2.6)

3 (2.5)

0.983

  Diabetes mellitus (n [%])

0 (0.0)

2 (0.9)

0 (0.0)

0.402

 Body mass index (kg/m2)*

21.5 ± 2.5

22.4 ± 2.9

22.2 ± 2.7

0.033

 Systolic blood pressure (mmHg)*

116 ± 11

117 ± 11

121 ± 12

0.008

 Diastolic blood pressure (mmHg)*

73 ± 9

74 ± 9

78 ± 10

<0.001

 Total cholesterol (mg/dL)

202 ± 30

203 ± 31

204 ± 35

0.893

 Triglyceride (mg/dL)

69 (48, 94)

69 (53, 100)

70 (50, 104)

0.484

 Hemoglobin A1c (%)

5.3 ± 0.2

5.3 ± 0.3

5.3 ± 0.3

0.124

 eGFR (mL/min/1.73 m2)

79 ± 12

79 ± 11

77 ± 11

0.365

 UACR (mg/gCr)*

29 (19, 49)

25 (18, 49)

36 (24, 64)

0.001

 Salt intake (g/day)

8.1 ± 1.7

8.3 ± 1.9

8.6 ± 1.7

0.106

Drinking frequency 1 year after the baseline visita

  Rare (n [%])

83 (91.2)

6 (2.6)

1 (0.8)

 

  Occasional

8 (8.8)

220 (93.6)

14 (11.5)

 

  Daily

0 (0.0)

9 (3.8)

107 (87.7)

 

Changes in salt intake and albuminuria over a 1-year period

 ∆Salt intake (g/day)

0.1 ± 1.8

0.0 ± 2.1

−0.4 ± 2.0

0.206

 ∆UACR (mg/gCr)

−1 (−12, 14)

2 (−6, 14)

−1 (−16, 12)

0.104

  1. Data are presented as mean ± standard deviation, median (25%, 75%), or n (%)
  2. eGFR estimated glomerular filtration rate, UACR urinary albumin-to-creatinine ratio
  3. *P < 0.05
  4. aThe weighted kappa statistics was 0.88 for reproducibility of drinking frequency at the baseline visit and 1 year after the baseline visit